Cargando…
Does Remdesivir maintain the race in the general treatment protocol of COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884325/ https://www.ncbi.nlm.nih.gov/pubmed/35280619 http://dx.doi.org/10.4103/jfmpc.jfmpc_1552_21 |
| _version_ | 1784660128588365824 |
|---|---|
| author | Thangaraju, Pugazhenthan Velmurugan, Hemasri |
| author_facet | Thangaraju, Pugazhenthan Velmurugan, Hemasri |
| author_sort | Thangaraju, Pugazhenthan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8884325 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88843252022-03-10 Does Remdesivir maintain the race in the general treatment protocol of COVID-19? Thangaraju, Pugazhenthan Velmurugan, Hemasri J Family Med Prim Care Letter to Editor Wolters Kluwer - Medknow 2021-12 2021-12-27 /pmc/articles/PMC8884325/ /pubmed/35280619 http://dx.doi.org/10.4103/jfmpc.jfmpc_1552_21 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to Editor Thangaraju, Pugazhenthan Velmurugan, Hemasri Does Remdesivir maintain the race in the general treatment protocol of COVID-19? |
| title | Does Remdesivir maintain the race in the general treatment protocol of COVID-19? |
| title_full | Does Remdesivir maintain the race in the general treatment protocol of COVID-19? |
| title_fullStr | Does Remdesivir maintain the race in the general treatment protocol of COVID-19? |
| title_full_unstemmed | Does Remdesivir maintain the race in the general treatment protocol of COVID-19? |
| title_short | Does Remdesivir maintain the race in the general treatment protocol of COVID-19? |
| title_sort | does remdesivir maintain the race in the general treatment protocol of covid-19? |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884325/ https://www.ncbi.nlm.nih.gov/pubmed/35280619 http://dx.doi.org/10.4103/jfmpc.jfmpc_1552_21 |
| work_keys_str_mv | AT thangarajupugazhenthan doesremdesivirmaintaintheraceinthegeneraltreatmentprotocolofcovid19 AT velmuruganhemasri doesremdesivirmaintaintheraceinthegeneraltreatmentprotocolofcovid19 |